NCT06859619View on ClinicalTrials.gov

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

NANot yet recruitingINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

October 3, 2025

Study Completion Date

October 3, 2025

Conditions
LeishmaniasisLeptospirosisBrucellosisQ FeverRickettsiosisTularemiaPsittacosisLyme DiseaseTick-borne EncephalitisHantaviral Infection NosHepatitis EDengue VirusZika VirusChikungunya Virus InfectionWest Nile VirusUsutu VirusToscana VirusCrimean-Congo Haemorrhagic Fever Virus
Interventions
OTHER

Peripheral venous blood sample

Peripheral venous blood sampling for IgG serology against leishmaniasis, leptospirosis, brucellosis, Q fever, rickettsiosis, tularemia, psittacosis, Lyme disease, tick-borne encephalitis, hantavirus, hepatitis E virus, dengue virus, Zika virus, Chikungunya virus, West Nile virus, Usutu virus, Toscana virus, Crimean-Congo hemorrhagic fever virus.

Trial Locations (1)

34295

University Hospital Of Montpellier, Montpellier

All Listed Sponsors
collaborator

TransVIHMI UM, IRD UMI233, Inserm U1175

UNKNOWN

collaborator

UMR 1058 Pathogenesis & Control of Chronic & Emerging Infections PCCEI

UNKNOWN

lead

University Hospital, Montpellier

OTHER